Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Haubrich

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|January 29, 2020
Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184VNicolas Margot, Renee Ram, Michael Abram, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 23, 2009
Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infectionSusanne May, Anthony Gamst, Richard Haubrich, et al.
AIDS (London, England)|October 21, 2006
Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole useMiguel Goicoechea, Brookie Best, Edmund Capparelli, et al.
AIDS Patient Care and Stds|April 21, 2006
Failure of modified directly observed therapy combined with therapeutic drug monitoring to enhance antiretroviral adherence in a patient with major depressionMiguel Goicoechea, Brookie Best, Edward Seefried, et al.
The Pediatric Infectious Disease Journal|October 1, 2015
High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral TherapySteve Innes, Kameelah L Abdullah, Richard Haubrich, et al.
AIDS and Behavior|January 25, 2015
Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEPJill Blumenthal, Sonia Jain, Douglas Krakower, et al.
AIDS Patient Care and Stds|September 7, 2002
Early adoption of HIV-1 resistance testing in the San Diego County Ryan White CARE Act Program: predictors and outcomeW Christopher Mathews, Jennifer Cole, Craig Ballard, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDSSusanne May, Scott Letendre, Richard Haubrich, et al.
HIV Clinical Trials|October 11, 2005
Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patientsTrevor Hawkins, Cindy Geist, Ben Young, et al.
Journal of Comparative Effectiveness Research|August 31, 2021
Comparative effectiveness research in COVID-19 using real-world data: methodological considerationsStephanie H Read, Artak Khachatryan, Aastha Chandak, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|January 29, 2020
Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184VNicolas Margot, Renee Ram, Michael Abram, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 23, 2009
Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infectionSusanne May, Anthony Gamst, Richard Haubrich, et al.
AIDS (London, England)|October 21, 2006
Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole useMiguel Goicoechea, Brookie Best, Edmund Capparelli, et al.
AIDS Patient Care and Stds|April 21, 2006
Failure of modified directly observed therapy combined with therapeutic drug monitoring to enhance antiretroviral adherence in a patient with major depressionMiguel Goicoechea, Brookie Best, Edward Seefried, et al.
The Pediatric Infectious Disease Journal|October 1, 2015
High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral TherapySteve Innes, Kameelah L Abdullah, Richard Haubrich, et al.
AIDS and Behavior|January 25, 2015
Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEPJill Blumenthal, Sonia Jain, Douglas Krakower, et al.
AIDS Patient Care and Stds|September 7, 2002
Early adoption of HIV-1 resistance testing in the San Diego County Ryan White CARE Act Program: predictors and outcomeW Christopher Mathews, Jennifer Cole, Craig Ballard, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDSSusanne May, Scott Letendre, Richard Haubrich, et al.
HIV Clinical Trials|October 11, 2005
Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patientsTrevor Hawkins, Cindy Geist, Ben Young, et al.
Journal of Comparative Effectiveness Research|August 31, 2021
Comparative effectiveness research in COVID-19 using real-world data: methodological considerationsStephanie H Read, Artak Khachatryan, Aastha Chandak, et al.
Pageof 11